Skip to main content
Equibles

LAZARD ASSET MANAGEMENT LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1207017 NEW YORK, NY
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,214,013
+$6,168,278 QoQ
Shares Held
19,659
+4419.3% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#97
of 415 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $404,338,249 across 60 Biotechnology names. LGND ranks #14 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 131,996 $122,461,928
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 93,287 $46,338,451
3 ONC
BeOne Medicines Ltd.
 90,348 $25,746,469
4 REGN
Regeneron Pharmaceuticals, Inc.
 36,910 $23,014,861
5 BMRN
Biomarin Pharmaceutical Inc
 350,397 $20,049,716
6 EXEL
Exelixis, Inc.
 343,029 $18,664,207
7 JAZZ
Jazz Pharmaceuticals plc
 69,588 $16,768,620
8 INCY
Incyte Corp
 136,684 $15,494,498

All Filings in LGND

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,214,013 19,659
2025-03-31 $45,735 435
2024-12-31 $70,611 659
2024-09-30 $216,794 2,166
2024-06-30 $182,507 2,166
2024-03-31 $86,623 1,185
2023-12-31 $84,632 1,185
2023-09-30 $71,005 1,185
2023-06-30 $39,222 544
2022-12-31 $485,569 7,269
2022-09-30 $625,932 7,269
2022-06-30 $79,048 886
2022-03-31 $99,666 886
2021-12-31 $133,916 867
2021-09-30 $111,734 802
2021-06-30 $114,660 874
2021-03-31 $131,716 864
2020-12-31 $85,924 864